Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.
about
Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trialsLong-term safety and efficacy of infliximab for the treatment of ankylosing spondylitisAnkylosing spondylitis: A state of the art factual backboneManaging cardiovascular risk in patients with inflammatory arthritis: practical considerationsArterial distensibility in chronic inflammatory rheumatic disordersWeight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.Endothelial dysfunction in chronic inflammatory diseasesCardiovascular involvement in autoimmune diseases.Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study.Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional studyInfliximab: 12 years of experienceIncreased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study.The importance of disease associations and concomitant therapy for the long-term management of psoriasis patientsCardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluation.On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study.Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitisCardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study.Spontaneous retrotransposon insertion into TNF 3'UTR causes heart valve disease and chronic polyarthritis.Cardiovascular risk in patients with psoriatic arthritis.Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the ClinicianAnkylosing spondylitis: recent breakthroughs in diagnosis and treatmentAssociation of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint DiseasesManagement and evaluation of extra-articular manifestations in spondyloarthritisCardiorespiratory fitness and cardiovascular risk in patients with ankylosing spondylitis: a cross-sectional comparative studyCardiovascular co-morbidity in rheumatic diseases.Predictors of Atherosclerosis in Ankylosing Spondylitis.Psoriatic arthritis and diabetes: a population-based cross-sectional studyNational Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO SyndromeTreatment recommendations for psoriatic arthritis.Genomic Variant in IL-37 Confers A Significant Risk of Coronary Artery Disease.Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritisGolimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.Perioperative care for patients with rheumatic diseases.Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management.Cardiovascular risk in juvenile idiopathic arthritis.Epidemiology of spondyloarthritis: a review.Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk.Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials.
P2860
Q26738520-081718D1-833E-46CD-8110-5639F12CA7B4Q26774173-C6073969-D08F-4FAE-AE11-83853D80E9F1Q26782184-A6609D1E-63B2-4BA9-BEAA-E068F015C8DDQ27694518-3C26E60D-8E4B-4040-928D-2942271D85F8Q30481548-28D04B8B-C2F1-49C2-B161-51414DE47720Q33659058-5C5542D4-9D44-4C77-A0C0-431D62C36D12Q34072179-AB86BDC2-5873-4285-ABAF-C31C2E8DECB7Q34081242-E34F0414-7327-4386-9F0B-5534A15E7FFBQ34731291-BE07D19A-F0CD-471A-BC69-F33C85398CC7Q34928996-6176BABB-7D49-46D6-A3D3-CA271E949E6CQ35070446-B1158422-B307-4C07-B393-B0FE2DD70668Q35142805-3CB09220-59B8-4759-9630-1D3B0D471B9AQ35230117-306843D3-3646-46F2-8FD7-2A2B43B9B7ADQ35496549-751AD9F1-8780-4EAF-BE3E-A8DDB7E4A58EQ35588201-8E8A6E0A-3944-42A2-A502-69840750B8C3Q35638180-255884D6-7872-487F-9F5F-9FA57501AADBQ35788272-2F48F04A-D9DA-4A51-A613-80F64444F9FBQ35946169-CF834B2D-D0C4-40D7-A26A-2080FB1BC439Q35974962-8493E5E7-DA3F-4813-B6B0-19F1B5BB9918Q36059338-F0D3EEDE-8F92-48DA-8AEB-07DFB5D06D7EQ36143588-BE3175CC-5D54-44E2-A39C-09072E808B1BQ36265758-BE3E214F-46CE-4229-B8B9-7B3120030FB0Q36439889-9B135113-1BD9-44DF-A034-15B382F44EDDQ36746588-ACEC4D5A-FB7D-4704-B589-551366F1172BQ36835851-63BAB0AD-B5ED-443E-A4AC-308B954AE0CDQ36943007-3B9A83F7-DDC1-44A7-81DD-DF9FD94EB7DAQ36988417-3B3197B8-6839-47B3-8F0F-3CC009441370Q37027264-9E45C1D0-A6D9-436B-9778-3794D45424B0Q37209974-A1B62BF0-5D93-46C0-A1A6-54D1D5D6D0ECQ37284516-7F9A2842-D8C5-4E83-B440-E16EBDB96D3CQ37633533-B0D5A97E-D1A3-465A-AA4A-49FE715407A8Q37672346-5BAB8E08-43E8-445A-976E-9B159B7FBB29Q37786627-C08C800C-2961-4F09-9C5D-313B5FD1DF07Q37956135-D57B891A-B15E-45EF-8B1A-C60CAD9AA4DDQ38025994-8556D178-592E-4A04-87F4-AD8B3B535E26Q38044505-0D2C125F-CFE8-4A5B-A818-0DA43763FB38Q38090373-5B710672-EF0F-4907-878A-34A6B29D2C9BQ38124275-60325501-3936-44C6-9F5D-27070D6C27E3Q38177340-CA663831-601F-4CED-AD22-683702D338B4Q38561891-13551812-7426-4D27-B93F-D26C48FAB1FB
P2860
Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cardiovascular risk profile of ...... litis and psoriatic arthritis.
@ast
Cardiovascular risk profile of ...... litis and psoriatic arthritis.
@en
type
label
Cardiovascular risk profile of ...... litis and psoriatic arthritis.
@ast
Cardiovascular risk profile of ...... litis and psoriatic arthritis.
@en
prefLabel
Cardiovascular risk profile of ...... litis and psoriatic arthritis.
@ast
Cardiovascular risk profile of ...... litis and psoriatic arthritis.
@en
P2093
P1476
Cardiovascular risk profile of ...... litis and psoriatic arthritis.
@en
P2093
Ben A Dijkmans
Irene E van der Horst-Bruinsma
Michael T Nurmohamed
Mike J Peters
P304
P356
10.1016/J.SEMARTHRIT.2004.07.010
P577
2004-12-01T00:00:00Z